Pneumococcal vaccination and revaccination in the elderly population
- PMID: 20113178
- DOI: 10.1086/651376
Pneumococcal vaccination and revaccination in the elderly population
Comment on
-
Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.J Infect Dis. 2010 Feb 15;201(4):525-33. doi: 10.1086/651131. J Infect Dis. 2010. PMID: 20088694 Clinical Trial.
-
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.J Infect Dis. 2010 Feb 15;201(4):516-24. doi: 10.1086/649839. J Infect Dis. 2010. PMID: 20092407 Clinical Trial.
Similar articles
-
Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil.Vaccine. 2004 Dec 21;23(6):762-8. doi: 10.1016/j.vaccine.2004.07.024. Vaccine. 2004. PMID: 15542200
-
[Splenectomy and pneumococcal vaccination].Ned Tijdschr Geneeskd. 2003 Jun 7;147(23):1142-3; author reply 1143. Ned Tijdschr Geneeskd. 2003. PMID: 12822528 Dutch. No abstract available.
-
Giving pneumococcal vaccine to mothers.Vaccine. 2007 Aug 14;25(33):6147. doi: 10.1016/j.vaccine.2007.05.051. Epub 2007 Jun 14. Vaccine. 2007. PMID: 17600595 No abstract available.
-
Experience with pneumococcal conjugate vaccine in Norway.Expert Rev Vaccines. 2009 Feb;8(2):159-65. doi: 10.1586/14760584.8.2.159. Expert Rev Vaccines. 2009. PMID: 19196196 Review.
-
Vaccines for other neonatal infections: pneumococcal disease: a major global health problem of young children.Expert Rev Vaccines. 2004 Aug;3(4):379-82. doi: 10.1586/14760584.3.4.379. Expert Rev Vaccines. 2004. PMID: 15270639 Review.
Cited by
-
Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged >2 years: A randomized, double-blinded, active control, phase III trial.Hum Vaccin Immunother. 2015;11(10):2425-33. doi: 10.1080/21645515.2015.1055429. Hum Vaccin Immunother. 2015. PMID: 26083953 Free PMC article. Clinical Trial.
-
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults.Hum Vaccin Immunother. 2015;11(9):2198-206. doi: 10.1080/21645515.2015.1030550. Epub 2015 Jul 15. Hum Vaccin Immunother. 2015. PMID: 26176163 Free PMC article. Clinical Trial.
-
Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.Hum Vaccin Immunother. 2013 Apr;9(4):865-73. doi: 10.4161/hv.23090. Epub 2013 Apr 1. Hum Vaccin Immunother. 2013. PMID: 23563516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical